249 related articles for article (PubMed ID: 17087311)
1. [Homocysteine and diabetic macroangiopathy].
Araki A
Nihon Rinsho; 2006 Nov; 64(11):2153-8. PubMed ID: 17087311
[TBL] [Abstract][Full Text] [Related]
2. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
3. [Homocysteine--a risk factor for atherosclerosis].
Debreceni L
Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine--relevant for atherogenesis?
Kircher T; Sinzinger H
Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
[TBL] [Abstract][Full Text] [Related]
5. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
6. [Homocysteinemia and vascular disease--a new risk factor is born].
Reis RP; Luís AS
Rev Port Cardiol; 1999 May; 18(5):507-14. PubMed ID: 10418265
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
[TBL] [Abstract][Full Text] [Related]
8. [Hyperhomocysteinemia hastens myocardial infarct and stroke. Prevention.with leaf salads and vitamins].
Meissner T
MMW Fortschr Med; 2003 Mar; 145(10):10. PubMed ID: 12688018
[No Abstract] [Full Text] [Related]
9. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease.
Boers GH
Semin Thromb Hemost; 2000; 26(3):291-5. PubMed ID: 11011846
[TBL] [Abstract][Full Text] [Related]
10. Significance of hyperhomocysteinemia.
Herrmann W
Clin Lab; 2006; 52(7-8):367-74. PubMed ID: 16955635
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
[TBL] [Abstract][Full Text] [Related]
13. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
Vermeulen EG; Stehouwer CD; Valk J; van der Knaap M; van den Berg M; Twisk JW; Prevoo W; Rauwerda JA
Eur J Clin Invest; 2004 Apr; 34(4):256-61. PubMed ID: 15086356
[TBL] [Abstract][Full Text] [Related]
14. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
16. [Homocysteine and cardiovascular risk].
Auer J; Berent R; Weber T; Lassnig E; Eber B
Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
[TBL] [Abstract][Full Text] [Related]
17. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL; Wang EE
CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
[TBL] [Abstract][Full Text] [Related]
18. [Hyperhomocysteinemia as a risk factor for venous thrombosis].
Willems HP; den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Bos GM
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):552-6. PubMed ID: 10321272
[TBL] [Abstract][Full Text] [Related]
19. [Status of homocysteine reduction in prevention of cardiovascular diseases. HOPE-2 study (Heart Outcomes Prevention Evaluation)].
Strasser RH
Internist (Berl); 2007 Mar; 48(3):327-9. PubMed ID: 17333057
[No Abstract] [Full Text] [Related]
20. [Group B vitamins as new variables related to the cardiovascular risk].
Granieri M; Bellisarii FI; De Caterina R
Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
